STBP Board Members24 July 2018 │ Geneva – Minister of Health of Kazakhstan, Dr. Elzhan A. Birtanov, and Minister of Health of Nigeria, Prof. Isaac Adewole, will represent Countries Affected by TB in the Stop TB Partnership’s Board (“Board”). The Private Sector will be represented on the Board by Dr. Adrian Thomas, Vice President of Global Health at Johnson & Johnson. The new Board Members will serve their terms effective immediately.

The Board has the responsibility of building awareness at the highest political level, identifying critical barriers in the TB space, and facilitating consensus on strategy and policy-making. It also oversees the effective implementation of the Stop TB Partnership’s Operational Strategy and the Global Plan to End TB: 2016-2020.

With the nomination of H.E. Minister Birtanov, Kazakhstan is positioning itself as a TB champion in Eastern Europe and Central Asia, putting significant political and advocacy efforts towards ending TB.

“I welcome the chance to represent Kazakhstan and play a proactive and constructive role in the Stop TB Partnership’s Board. Detecting, treating and curing people with TB is clearly a priority for Kazakhstan, and we are convinced that working together with the Stop TB Partnership will bring us closer to this goal,” said Minister Birtanov adding that “it is imperative for all countries to step-up, unite forces and assure the highest representation for a successful UN HLM on TB in September.”

The Stop TB Partnership Board in action: 30th Board Meeting in New Delhi, March 2018

The Stop TB Partnership Board in action: 30th Board Meeting in New Delhi, March 2018

“It is a privilege to receive guidance and support from such an outstanding Board that includes six Ministers of Health,” said Dr. Lucica Ditiu, Executive Director of the Stop TB Partnership. “Ministers of Health of Kazakhstan and Nigeria bring huge expertise, professionalism and political clout to our Board. The selection of Dr. Adrian Thomas is a strong message to the TB community that it is high time to stop shying away but work together with the private sector to develop and deliver joint solutions and innovations that push forward people-centered care and save lives,” Dr. Ditiu concluded.

The Private Sector Constituency is one of the voting members at the Board and ensures the business community’s perspectives and expertise.

The United Nations high-level meeting (HLM) on TB will take place on 26 September 2018 during the UN General Assembly in New York City.

The Stop TB Partnership’s 31st Board Meeting will be held from 27-29 January 2019 in Geneva.

For more information see the Stop TB Partnership Announcement.


This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020).

The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.